(VIANEWS) - BRT Realty Trust (BRT), Gilead Sciences (GILD), Premier Financial Bancorp (PFBI) are the highest dividend yield stocks on this list.
| Rank |
Financial Asset |
Price |
Change |
Forward Dividend Yield |
Updated (EST) |
| 1 |
BRT Realty Trust (BRT) |
20.52 |
-0.05% |
4.29% |
2021-09-07 03:46:06 |
| 2 |
Gilead Sciences (GILD) |
71.48 |
0.41% |
4.1% |
2021-09-08 09:12:54 |
| 3 |
Premier Financial Bancorp (PFBI) |
18.02 |
-0.22% |
3.33% |
2021-09-04 22:11:05 |
| 4 |
Morgan Stanley (MS) |
104.16 |
-0.02% |
3.1% |
2021-09-08 08:55:42 |
| 5 |
First National Corporation (FXNC) |
21.15 |
0.09% |
2.27% |
2021-09-06 00:06:05 |
| 6 |
Mid (MAA) |
192.42 |
-1.9% |
2.18% |
2021-09-07 15:15:51 |
| 7 |
Lakeland Financial Corporation (LKFN) |
67.14 |
-0.47% |
2.03% |
2021-09-04 16:12:05 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. BRT Realty Trust (BRT) - Dividend Yield: 4.29%
BRT is a real estate investment trust that owns, operates and develops multi-family properties.
Volume
Today's last reported volume for BRT Realty Trust is 51602, 14.68% above its average volume of 44998.
BRT Realty Trust's last close was $20.52, 5.44% below its 52-week high of $21.70.
The company's growth estimates for the present quarter and the next is 192% and 59.1%, respectively.
BRT Realty Trust's Revenue
Year-on-year quarterly revenue growth grew by 19.2%, now sitting on 23.76M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
BRT Realty Trust's stock is considered to be overbought (>=80).
BRT Realty Trust's Stock Yearly Top and Bottom Value
BRT Realty Trust's stock is valued at $20.52 at 10:15 EST, under its 52-week high of $21.70 and way higher than its 52-week low of $11.05.
BRT Realty Trust's Moving Average
BRT Realty Trust's worth is way higher than its 50-day moving average of $18.26 and way above its 200-day moving average of $17.92.
More news about
BRT Realty Trust.
2. Gilead Sciences (GILD) - Dividend Yield: 4.1%
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases. It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of viral diseases, inflammatory and fibrotic diseases, and oncology. The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Second Genome; Gadeta; Carna Biosciences Inc.; Nurix Therapeutics, Inc.; Humanigen, Inc.; Kiniksa Pharmaceuticals, Ltd.; Kyverna Therapeutics, Inc.; Glympse Bio, Inc.; Renown Institute for Health Innovation; Goldfinch Bio, Inc.; Insitro, Inc.; Novo Nordisk A/S; Yuhan Corporation; Kite Pharma, Inc.; oNKo-innate Pty. Ltd.; and Roche Holding AG. The company has partnership with Arcus Biosciences, Inc. to co-develop and co-commercialize next-generation cancer immunotherapies. Gilead Sciences, Inc. was founded in 1987 and is headquartered in Foster City, California.
Volume
Today's last reported volume for Gilead Sciences is 592701, 90.47% below its average volume of 6217050.
Gilead Sciences's last close was $71.96, 1.88% under its 52-week high of $73.34.
The company's growth estimates for the present quarter is 55.9% and a drop 20.4% for the next.
Gilead Sciences's Revenue
Year-on-year quarterly revenue growth grew by 20.9%, now sitting on 26.64B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Gilead Sciences's stock is considered to be overbought (>=80).
Gilead Sciences's Stock Yearly Top and Bottom Value
Gilead Sciences's stock is valued at $71.48 at 10:15 EST, under its 52-week high of $73.34 and way above its 52-week low of $56.56.
Gilead Sciences's Moving Average
Gilead Sciences's worth is higher than its 50-day moving average of $70.43 and higher than its 200-day moving average of $67.23.
More news about
Gilead Sciences.
3. Premier Financial Bancorp (PFBI) - Dividend Yield: 3.33%
Premier Financial Bancorp, Inc., a multi-bank holding company, provides community banking services to individuals and small-to-medium sized businesses. The company accepts various deposit products, including checking, NOW, savings, money market, club, individual retirement, and overdraft protection accounts, as well as certificates of deposit. It also provides loans secured by 1-4 family residential real estate, multifamily residential real estate, owner occupied non-farm non-residential real estate, and non-farm non-residential real estate; commercial and industrial loans not secured by real estate; consumer loans; construction, land, and land development loans; and farmland and agricultural loans, and loans to tax-exempt entities. In addition, the company offers depository and funds transfer services; collections; safe deposit boxes; cash management services; bill payment, remote deposit, check imaging, and automated teller machine services; and internet, mobile, and telephone banking services. As of March 6, 2020, it operated thirteen banking offices in Kentucky; three banking offices in Ohio; twenty-six banking offices in West Virginia; four banking offices in Washington, DC; one banking office in Maryland; and three banking offices in Virginia. The company was incorporated in 1991 and is headquartered in Huntington, West Virginia.
Volume
Today's last reported volume for Premier Financial Bancorp is 7907, 71.1% below its average volume of 27356.
Premier Financial Bancorp's last close was $18.02, 6.63% below its 52-week high of $19.30.
Premier Financial Bancorp's Revenue
Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 74.24M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Premier Financial Bancorp's stock is considered to be overbought (>=80).
Premier Financial Bancorp's Stock Yearly Top and Bottom Value
Premier Financial Bancorp's stock is valued at $18.02 at 10:15 EST, below its 52-week high of $19.30 and way above its 52-week low of $10.10.
Premier Financial Bancorp's Moving Average
Premier Financial Bancorp's value is above its 50-day moving average of $17.50 and higher than its 200-day moving average of $17.74.
More news about
Premier Financial Bancorp.
4. Morgan Stanley (MS) - Dividend Yield: 3.1%
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides sales and trading services, including sales, financing, prime brokerage, and market-making services in equity and fixed income products consisting of foreign exchange and commodities; corporate and commercial real estate loans, which provides secured lending facilities and financing for sales and trading customers, as well as asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers various financial services and solutions covering brokerage and investment advisory services; financial and wealth planning services; stock plan administration services; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; and banking and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides various investment strategies and products comprising equity, fixed income, liquidity, and alternative/other products to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, and third-party fund sponsors and corporations through a network of institutional and intermediary channels. Morgan Stanley was founded in 1924 and is headquartered in New York, New York.
Volume
Today's last reported volume for Morgan Stanley is 226708, 97.44% below its average volume of 8851550.
Morgan Stanley's last close was $104.25, 1.47% under its 52-week high of $105.81.
The company's growth estimates for the present quarter and the next is a negative 3.6% and a negative 9.9%, respectively.
Morgan Stanley's Revenue
Year-on-year quarterly revenue growth grew by 68.8%, now sitting on 54.64B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Morgan Stanley's stock is considered to be overbought (>=80).
Morgan Stanley's Stock Yearly Top and Bottom Value
Morgan Stanley's stock is valued at $104.16 at 10:15 EST, under its 52-week high of $105.81 and way higher than its 52-week low of $45.86.
Morgan Stanley's Moving Average
Morgan Stanley's value is higher than its 50-day moving average of $100.41 and way higher than its 200-day moving average of $88.91.
Previous days news about Morgan Stanley
- Morgan stanley expands hunt for black traders to London. According to Bloomberg Quint on Tuesday, 7 September, "The Morgan Stanley Experienced Professionals Program is aimed at recruiting Black or female candidates already working in other industries that might not have considered a career at a bank. ", "Everything I've heard and everything I've experienced has been that Morgan Stanley has been in line historically with the rest of the Street, which is not where you want to be, right?"
- Morgan stanley initiates coverage of oil refiners, names hollyfrontier, valero & marathon top picks. According to Benzinga on Tuesday, 7 September, "The Analyst: Morgan Stanley analyst Connor Lynagh initiated coverage of the following stocks:", "Benzinga's Take: If Morgan Stanley believes the fate of oil refiners is tied closely to jet fuel demand, that means the bull case for refiner stocks in the near term is all about vaccination rates and the spread of the delta variant of COVID-19. "
- Adaptive biotechnologies to present at the morgan stanley global healthcare conference. According to Benzinga on Tuesday, 7 September, "SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference."
- Somalogic to present at morgan stanley 19th annual global healthcare conference. According to Benzinga on Tuesday, 7 September, "NEW YORK and BOULDER, Colo., Sept. 07, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Morgan Stanley 19th Annual Global Healthcare Conference."
More news about
Morgan Stanley.
5. First National Corporation (FXNC) - Dividend Yield: 2.27%
First National Corporation operates as the bank holding company for First Bank that provides various commercial banking services to small and medium-sized businesses, individuals, estates, local governmental entities, and non-profit organizations in Virginia. The company's deposit products include checking, savings, money market, and individual retirement accounts, as well as certificates of deposit and treasury management solutions. Its loan products comprise construction loans, including residential, land acquisition, and development loans; 1-4 family residential real estate loans; and commercial real estate loans that are secured by various types of commercial real estate, including multi-family residential buildings, office and retail buildings, hotels, industrial buildings, and religious facilities. The company's loan products also include commercial and industrial loans that are secured by business assets, such as accounts receivable, equipment, and inventory; home equity loans; and secured and unsecured consumer loans, such as lines of credit, automobile loans, deposit account loans, and installment and demand loans. In addition, it provides wealth management services, including estate planning, investment management of assets, trustee under an agreement, trustee under a will, and estate settlement. Further, the company offers title insurance and investment services; and holds other real estate owned and office sites, as well as provides internet and mobile banking, remote deposit capture, and other traditional banking services. It serves customers through 14 bank branch offices, a loan production office, and a customer service center, as well as through a network of ATMs. The company was founded in 1907 and is headquartered in Strasburg, Virginia.
Volume
Today's last reported volume for First National Corporation is 5759, 30.81% below its average volume of 8323.
First National Corporation's last close was $21.15, 11.4% below its 52-week high of $23.87.
First National Corporation's Revenue
Year-on-year quarterly revenue growth grew by 30.4%, now sitting on 38.7M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
First National Corporation's stock is considered to be overbought (>=80).
First National Corporation's Stock Yearly Top and Bottom Value
First National Corporation's stock is valued at $21.15 at 10:15 EST, way under its 52-week high of $23.87 and way above its 52-week low of $13.25.
First National Corporation's Moving Average
First National Corporation's worth is below its 50-day moving average of $21.40 and higher than its 200-day moving average of $19.44.
More news about
First National Corporation.
6. Mid (MAA) - Dividend Yield: 2.18%
MAA, an S&P 500 company, is a real estate investment trust, or REIT, focused on delivering full-cycle and superior investment performance for shareholders through the ownership, management, acquisition, development and redevelopment of quality apartment communities in the Southeast, Southwest, and Mid-Atlantic regions of the United States. As of June 30, 2020, MAA had ownership interest in 102,105 apartment units, including communities currently in development, across 16 states and the District of Columbia.
Volume
Today's last reported volume for Mid is 389511, 31.54% below its average volume of 568979.
Mid's last close was $196.14, 0.88% above its 52-week high of $194.42.
Mid's Sales
Mid's sales growth is 4.4% for the current quarter and 5.3% for the next. The company's growth estimates for the current quarter is 23.1% and a drop 2.8% for the next.
Mid's Revenue
Year-on-year quarterly revenue growth grew by 1.7%, now sitting on 1.68B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Mid's stock is considered to be overbought (>=80).
Mid's Stock Yearly Top and Bottom Value
Mid's stock is valued at $192.42 at 10:15 EST, below its 52-week high of $194.42 and way higher than its 52-week low of $109.88.
Mid's Moving Average
Mid's value is above its 50-day moving average of $175.17 and way above its 200-day moving average of $152.68.
More news about
Mid.
7. Lakeland Financial Corporation (LKFN) - Dividend Yield: 2.03%
Lakeland Financial Corporation operates as the bank holding company for Lake City Bank that provides various banking products and services. The company accepts various deposit products, such as noninterest bearing, interest-bearing checking, savings, money market, NOW, and demand deposits. Its loan products include commercial and industrial, commercial real estate and multi-family residential, agri-business and agricultural, consumer 1-4 family mortgage, and other consumer loans. The company also offers retail and merchant credit card services; corporate treasury management, wealth advisory, and trust services; retail brokerage services, including various financial and investment products, such as annuities and life insurance; and internet business banking and on-line treasury management services. It serves commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and health care industries. As of December 31, 2020, the company operated 50 offices in fifteen counties, including 44 offices in northern Indiana and six offices in central Indiana. Lakeland Financial Corporation was founded in 1872 and is headquartered in Warsaw, Indiana.
Volume
Today's last reported volume for Lakeland Financial Corporation is 209776, 22.47% below its average volume of 270564.
Lakeland Financial Corporation's last close was $67.14, 12.86% below its 52-week high of $77.05.
Lakeland Financial Corporation's Sales
Lakeland Financial Corporation's sales growth is 6.5% for the current quarter and 1.9% for the next. The company's growth estimates for the ongoing quarter is 4.5% and a drop 1% for the next.
Lakeland Financial Corporation's Revenue
Year-on-year quarterly revenue growth grew by 25.5%, now sitting on 218.31M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Lakeland Financial Corporation's stock is considered to be overbought (>=80).
Lakeland Financial Corporation's Stock Yearly Top and Bottom Value
Lakeland Financial Corporation's stock is valued at $67.14 at 10:15 EST, way below its 52-week high of $77.05 and way above its 52-week low of $39.38.
Lakeland Financial Corporation's Moving Average
Lakeland Financial Corporation's worth is higher than its 50-day moving average of $65.92 and higher than its 200-day moving average of $65.64.
More news about
Lakeland Financial Corporation.
